Science Group Plc · LSE:SAG
Science — H1 2017 Earnings Presentation
9 slides from Science's earnings presentation, Jul 25, 2017
Slide 1: Interim Results Presentation July 2017
Interim Results Presentation July 2017 Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director To be read in conjunction with the Interim Results announcement released on 25 July 2017 1
Slide 2: Science Group plc - Overview
Science Group plc - Overview Science and technology services • Science-based Consultancy and Advisory Services • Technology & Product Development Four subsidiary companies/brands • Sagentia – founded 1986, servicing medical and commercial markets • OTM Consulting – acq July 2013, servicing the oil a
Slide 3: Financial Summary
Financial Summary • Group revenue of £18.0m (H1-16: £17.7m) • 80% of Core Business revenue from international markets • 32% of Core Business revenue invoiced in US Dollars and 9% in Euros • Adjusted* operating profit of £3.2m (H1-16: £2.5m) • Beneficial foreign exchange rates compared to H1-16 • Cur
Slide 4: Services Revenue Profile – H1 2017
Services Revenue Profile – H1 2017 • Science Group comprises five operating businesses • Four distinct brands under Science Group umbrella brand Market Overview • Medical: Strong recovery performance in the period Leatherhead Sagentia Medical • Commercial: Quieter period due to major projects comple
Slide 5: Group Revenue (5 Year)
Group Revenue (5 Year) • Good organic growth in Outsourced Product Development (Sagentia) business on actual and/or constant currency measure. Driven by recovery in Medical sector • Non-core property rental income from Harston site stable 20 18 16 Non Core: Property income 14 Revenue (£m) 12 Other c
Slide 6: International Services Business
International Services Business • 80% of Core Business revenue derived from international markets • 32% of Core Business revenue invoiced in US$ (H1-16: 35%) and 9% in Euro (H1-16: 11%) • Remaining international clients, primarily in Europe, are invoiced in GBP • Over 90% of employees are based in t
Slide 7: Adjusted Operating Profit
Adjusted Operating Profit • Sagentia aggregate contribution increased due to strong Medical sector performance • Foreign exchange benefit in H1-17 compared to H1-16 • Continuing to use part of FX benefit to increase investment 4.0 24.0% 3.5 Adjusted operating profit margin (%) 3.0 18.0% Adjusted ope
Slide 8: Currency Exchange Rates
Currency Exchange Rates • Foreign exchange benefit in H1-17 compared to H1-16 • Average USD rate of 1.26 in H1-17 (H1-16: 1.44 and H2-16: 1.29) • Average Euro rate of 1.17 in H1-17 (H1-16: 1.30 and H2-16: 1.17) • Exchange rates for H1-17 broadly equivalent to H2-16 levels 1.60 1.50 Exchange rate 1.4
Slide 9: www.sciencegroup.com
www.sciencegroup.com Head office Epsom London Harston Mill Great Burgh 48-49 St James's Street Harston, Cambridge Yew Tree Bottom Road London CB22 7GG Epsom SW1A 1JT UK Surrey UK KT18 5X 5XT Phone: +44 1223 875200 Phone: +44 1372 376761 Phone: +44 207 014 3250 info@sciencegroup.com info@sciencegroup